Picture of INVO Fertility logo

IVF — INVO Fertility News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Naya Biosciences Inc Expected To Post A Loss Of $3.48 A Share: Earnings Preview

NAYA Biosciences Inc NAYA.OQ NAYA.O is expected to report resultson April 14 (estimated) for the period ending December 31 2024

The Sarasota Florida-based  company is expected to report revenue of $1.5 million, according to the estimate from one analyst, based on LSEG data.

​LSEG's mean analyst estimate for NAYA Biosciences Inc is for a loss of $3.48 per share.

The one available analyst rating on the shares is "buy".

The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "Buy".​

Wall Street's median 12-month price target for NAYA Biosciences Inc is $24.00​, above​ its last closing price of $1.72. ​​​

This summary was machine generated April 11 at 11:08 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on INVO Fertility

See all news